Abstract:Background: Sepsis is mainly characterized by a dysregulated host response to infection and cytokine storm syndrome is one of the main pathogenic mechanisms of sepsis. Interleukin-3 (IL-3), a pro-inflammatory factor, has a multifaceted role in inflammatory diseases. However, its role in the pathogenesis of sepsis remains unknown.Methods: Serum levels of IL-3 were measured and analyzed in 38 Intensive Care Unit (ICU) patients with sepsis, 36 non-septic ICU patient controls, and 30 healthy volunteers. The effects of IL-3 on survival, inflammation, tissue damage, bacterial clearance, and the MAPK pathway were assessed using 2 male mouse models: cecum puncture and ligation (CLP)-induced sepsis and lipopolysaccharide (LPS)-induced sepsis.Results: Serum IL-3 levels were significantly higher in patients with sepsis on the day of diagnosis compared to ICU patient controls and healthy volunteers. Patients with septic shock showed significantly higher serum IL-3 levels compared to non-shocked patients. Serum interleukin-3 levels were correlated with sequential (sepsis-related) organ failure assessment scores (SOFA). Serum IL-3 level could discriminate septic shock from sepsis. Anti-IL-3 antibodies prolong survival time, recombinant IL-3 shortens survival time in two mouse models of CLP-induced sepsis and LPS-induced sepsis. Anti-IL-3 antibody application reduced inflammatory factor release (including IL-3, Interleukin-6 (IL-6), Interleukin1-β (IL-1β), and Tumor necrosis factor-α(TNF-α)); attenuated organ damage (including lung, liver, and kidney); enhanced bacterial clearance; attenuated splenic tissue inflammatory factor (including IL-3, IL-6, IL-1β, and TNF-α) protein content; and down-regulated phosphorylated p38, ERK, JNK protein content in MAPK pathway in lung, liver, and kidney. Recombinant IL-3 application promotes the release of inflammatory factors (including IL-3, IL-6, IL-1β, and TNF-α); exacerbates organ damage (including lung, liver, and kidney); reduces bacterial clearance; increases inflammatory factors (including IL-3, IL-6, IL-1-β, and TNF-α) protein content in splenic tissues; upregulates phosphorylated p38, ERK, JNK protein content in MAPK pathway in lung, liver, and kidney.Conclusions: Serum IL-3 levels are elevated in patients with sepsis, which may correlate with the severity of the disease. In experimental sepsis, we demonstrated that inhibition of IL-3 prolongs survival time, whereas IL-3 plays the opposite role. Anti-IL-3 may be a new target for sepsis treatment.

Interleukin 6 Increases Dysfunction of Organs in Sepsis Rats Through Sirtuin 1

Sirt3 is a Novel Target to Treat Sepsis Induced Myocardial Dysfunction by Acetylated Modulation of Critical Enzymes Within Cardiac Tricarboxylic Acid Cycle

Effect of Interleukin-36β on Activating Autophagy of CD4+CD25+ Regulatory T Cells and Its Immune Regulation in Sepsis.

Effect of HSP70 Gene Transfection to Rat Peripheral Blood Cytokines in the Early Phase of Sepsis

GAS6 attenuates sepsis-induced cardiac dysfunction through NLRP3 inflammasome-dependent mechanism

SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model

Inhibition of Interleukin-3 Reversed the Inflammatory Response and Organ Damage Induced by Sepsis

Expression Change and Research of the Roles of Sirt-2 in Liver Tissue of Sepsis Mice

Resveratrol Protects the Myocardium in Sepsis by Activating the Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway and Inhibiting the Nuclear Factor-κB (NF-κB) Signaling Pathway

Activation of sigma-1 receptor ameliorates sepsis-induced myocardial injury by mediating the Nrf2/HO1 signaling pathway to attenuate mitochondrial oxidative stress

IL-6/STAT3 Signaling Promotes Cardiac Dysfunction by Upregulating FUNDC1-Dependent Mitochondria-Associated Endoplasmic Reticulum Membranes Formation in Sepsis Mice

microRNA-590-3p regulates inflammation and organ dysfunction in sepsis mouse model via the Syap1-mediated TGF-β/Smad signaling pathway

Role of sirtuins in sepsis and sepsis-induced organ dysfunction: A review

CD1d-dependent natural killer T-cells inactivation aggravates sepsis-induced myocardial injury via T lymphocytes infiltration and IL-6 production in mice

A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction?

Ginsenoside Rg1 Regulates SIRT1 to Ameliorate Sepsis-Induced Lung Inflammation and Injury via Inhibiting Endoplasmic Reticulum Stress and Inflammation

The role and therapeutic potential of SIRTs in sepsis

MicroRNA-146a improves sepsis-induced cardiomyopathy by regulating the TLR-4/NF-κB signaling pathway

Regulatory role of the TLR4/JNK signaling pathway in sepsis‐induced myocardial dysfunction

Impact of interleukin 6 levels on acute lung injury risk and disease severity in critically ill sepsis patients

DLK1 overexpression improves sepsis-induced cardiac dysfunction and fibrosis in mice through the TGF-β1/Smad3 signaling pathway and MMPs